J. Rey

发表

Milnacipran (Savella), a Treatment Option for Fibromyalgia

C. English, J. Rey, Chabely Rufin, 2010 .

Opicapone: A third generation COMT inhibitor

J. Rey, J. Greenwood, Huy Pham, 2020, Clinical parkinsonism & related disorders.

Sibutramine: A Serotonin–Norepinephrine Reuptake-Inhibitor for the Treatment of Obesity

J. Rey, C. Luque, Jose A Rey, 1999, The Annals of pharmacotherapy.

The discovery and status of sibutramine as an anti-obesity drug.

J. Rey, C. Luque, 2002, European journal of pharmacology.

Abrupt Discontinuation of Fenfluramine and Dexfenfluramine May Cause Serotonin Withdrawal Syndrome

J. Rey, G. Jamison, A. L. Lazowick, 1998 .

Phentermine/Topiramate extended-release capsules (qsymia) for weight loss.

J. Rey, David J Lonneman, B. McKee, 2013, P & T : a peer-reviewed journal for formulary management.

Pharmaceutical services at a medical site after Hurricane Andrew.

J. Rey, A. Avilés, A. Nestor, 1993, American journal of hospital pharmacy.

Lorcaserin (Belviq): A Selective Serotonin 5-HT2C Agonist In the Treatment of Obesity.

J. Rey, A. Gustafson, Camille King, 2013, P & T : a peer-reviewed journal for formulary management.

Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder

J. Rey, Huy Pham, Halford Warlick, 2022, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.

Pharmacological Agents for the Treatment of Adult Attention Deficit Hyperactivity Disorder: A Review of the Literature

J. Rey, Devon A. Sherwood, 2006 .

Tetrabenazine (Xenazine), An FDA-Approved Treatment Option For Huntington's Disease-Related Chorea.

J. Rey, T. Yero, 2008, P & T : a peer-reviewed journal for formulary management.

Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant.

J. Rey, Alicia Lopez, R. Bahr, 2019, P & T : a peer-reviewed journal for formulary management.

Invega Trinza: The First Four-Times-a-Year, Long-Acting Injectable Antipsychotic Agent.

J. Rey, Noor Daghistani, 2016, P & T : a peer-reviewed journal for formulary management.

Role of paliperidone palmitate 3-monthly in the management of schizophrenia: insights from clinical practice

J. Rey, Alicia Lopez, 2019, Neuropsychiatric disease and treatment.

Atypical Antipsychotics in Children with Pervasive Developmental Disorders

J. Rey, Mapy Chávez-Brown, Benjamin Chavez, 2007, Paediatric drugs.

Flibanserin (Addyi)

J. Rey, A. Muhleisen, 2017 .

A Case of Myotonia Congenita and Schizophrenia: Difficulties in Treatment with Antipsychotics due to Hypersensitivity to Extrapyramidal Symptoms

J. Rey, Huy Pham, Jose A. Rey, 2019, International Journal of Psychiatry and Mental Health.

The Interface of Multiculturalism and Psychopharmacology

J. Rey, 2006 .

Retroperitoneal paraganglioma. Differential diagnosis with hypernephroma

J. Rey, J. Esquivel, M. P. Alvarez, 1997 .

Application of gabapentinoids and novel compounds for the treatment of benzodiazepine dependence: the glutamatergic model

J. Rey, Halford Warlick, Arkene Levy, 2022, Molecular Biology Reports.

Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.

J. Rey, Shannon C. Eaves, 2016, P & T : a peer-reviewed journal for formulary management.

Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults.

J. Rey, S. Ungureanu, M. Sherman, 2016, P & T : a peer-reviewed journal for formulary management.

Loxapine inhalation powder (adasuve): a new and innovative formulation of an antipsychotic treatment for agitation.

J. Rey, J. Valdes, T. Shipley, 2014, P & T : a peer-reviewed journal for formulary management.

Vortioxetine (brintellix): a new serotonergic antidepressant.

C. English, J. Rey, Andrew D'Agostino, 2015, P & T : a peer-reviewed journal for formulary management.

Clinically Significant Interactions with Benzodiazepines

D. Boggs, J. Rey, J. Valdes, 2016 .

Lumateperone: A Novel Antipsychotic for Schizophrenia

J. Rey, J. Greenwood, V. Marcellus, 2020, The Annals of pharmacotherapy.

PerserisTM: A New and Long-Acting, Atypical Antipsychotic Drug-Delivery System.

J. Rey, A. Karas, G. Burdge, 2019, P & T : a peer-reviewed journal for formulary management.

Risperdal Consta TM : The First Long-Acting Atypical Antipsychotic Agent

S. Thompson, J. Rey, 2004 .

Pregabalin ( Lyrica ) : A New Treatment Option for Neuropathic Pain and Partial Seizures

J. Rey, J. Roe, E. Velez, 2006 .

Iloperidone (Fanapt): An FDA-Approved Treatment Option for Schizophrenia

J. Rey, A. Montes, 2009 .

Prevalence of hazardous alcohol use among pharmacy students at nine U.S. schools of pharmacy

C. English, J. Rey, Lauren S. Schlesselman, 2011, Pharmacy practice.

Psychiatry: Role of Risperidone in Children with Autism Spectrum Disorder

J. Rey, Mapy Chávez-Brown, Benjamin Chavez, 2006, The Annals of pharmacotherapy.

Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity.

J. Rey, C. Luque, 1999, The Annals of pharmacotherapy.

Weight gain and metabolic disturbances associated with the atypical antipsychotics.

J. Rey, R. Rivas-Vazquez, 2002 .

N-Methyl-D-Aspartate (NMDA) Receptors

J. Rey, 2018 .

Comparative analysis of p53, Ki-67, bcl-2 and CK20 expression in superficial transitional cell carcinoma of urinary bladder: correlation with recurrence, histological grade and clinical stage

J. Rey, C. Álvarez, A. Costas, 2003 .

Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive Dyskinesia.

J. Rey, Stepan Uhlyar, 2018, P & T : a peer-reviewed journal for formulary management.